Clinical Trial: Effect of Intracoronary N-Acetylcysteine in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06850831) titled 'Effect of Intracoronary N-Acetylcysteine in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention' on Feb. 23.

Brief Summary: Primary percutaneous coronary intervention (PCI) is the gold standard for reperfusion therapy in patients with ST-elevation myocardial infarction (STEMI), as it restores blood flow by clearing the blocked coronary artery. This process helps reoxygenate the previously hypoxic myocardium, potentially preventing further myocardial cell death. However, despite its benefits, reperfusion therapy, including primary PCI, can also lead to reperfusion injury, which may w...